FATE
Fate Therapeutics, Inc.
Set alert
2.08 USD -0.09 -4.15%
2.01 Day range 2.16
0.96 52-week range 3.11
- YTD
- +112.24%
- 1 year
- +61.24%
- Open
- 2.13
- Prev close
- 2.17
- Mkt cap
- 249.23M
- Vol
- 1.06M
- Avg vol
- 1.58M
- EPS
- -1.05
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 2.01
- High
- 2.16
- Forward P/E
- -0.99
- Beta
- 1.88
- Short ratio
- 3.10
- Inst. own
- 102.25%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 2.53
- 200-d avg
- 3.93
- 1y target
- 6.31
Peers
Companies in the same industry
| Symbol | Name | Last | Change | Change % | YTD | Market cap |
|---|---|---|---|---|---|---|
| SRPT | Sarepta Therapeutics, Inc. | 18.62 | -0.61 | -3.17% | -13.48% | 1.97B |
| BDX | Becton, Dickinson and Company | 197.88 | -0.46 | -0.23% | +29.70% | 53.90B |
| PTCT | PTC Therapeutics, Inc. | 59.97 | -4.49 | -6.97% | -21.05% | 5.01B |
| RNA | Atrium Therapeutics, Inc. | 8.27 | +0.01 | +0.12% | -43.93% | 141.46M |
| NBIX | Neurocrine Biosciences, Inc. | 146.10 | -0.28 | -0.19% | +3.01% | 14.85B |